Angiopoietin-1 induces sprouting angiogenesis in vitro

Area of Science:

• Molecular Biology
• Cell Biology
• Developmental Biology

Background:

• Angiogenesis, the formation of new blood vessels, is crucial for embryonic development and tumor growth.
• Vascular endothelial growth factor (VEGF) and angiopoietins (like Ang1) with Tie receptors are key regulators of blood vessel formation.
• Previous studies showed Tie2 receptor or Ang1 gene deficiency causes embryonic lethality, but in vitro activity was unknown.

Purpose of the Study:

• To investigate the in vitro biological activity of angiopoietin-1 (Ang1) on endothelial cells.
• To compare the effects of Ang1 with vascular endothelial growth factor (VEGF) on capillary sprout formation.
• To understand the role of the Ang1-Tie2 system in blood vessel development.

Main Methods:

• Endothelial cells were cultured on microcarrier beads within three-dimensional fibrin gels.
• Recombinant Ang1 was added at varying concentrations (0.5-10 nM) to assess its effect on capillary sprouting.
• The effect of soluble Tie2 receptor extracellular domains on Ang1-induced sprouting was evaluated.
• Synergistic effects of suboptimal concentrations of VEGF and Ang1 were tested.

Main Results:

• Recombinant Ang1 dose-dependently induced capillary sprout formation in vitro.
• Ang1-induced sprouting was completely inhibited by soluble Tie2 receptor domains.
• Ang1 showed weak mitogenic activity compared to VEGF, but synergized with suboptimal VEGF concentrations to promote sprouting.

Conclusions:

• The in vitro biological activity of Ang1 supports its critical role in blood vessel formation, consistent with in vivo knockout phenotypes.
• Ang1 and VEGF act synergistically, suggesting a hierarchical control of blood vessel formation involving multiple signaling pathways.
• The Ang1-Tie2 system is a significant regulator in the hierarchy of master-control genes for blood vessel development.